Cargando…

Ibrutinib in Relapsed or Refractory Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia

Detalles Bibliográficos
Autores principales: Peterson, Derek, Schwartz, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457173/
https://www.ncbi.nlm.nih.gov/pubmed/26114015
_version_ 1782374950864158720
author Peterson, Derek
Schwartz, Joanna
author_facet Peterson, Derek
Schwartz, Joanna
author_sort Peterson, Derek
collection PubMed
description
format Online
Article
Text
id pubmed-4457173
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Harborside Press
record_format MEDLINE/PubMed
spelling pubmed-44571732015-06-25 Ibrutinib in Relapsed or Refractory Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia Peterson, Derek Schwartz, Joanna J Adv Pract Oncol Review Article Harborside Press 2014 2014-09-01 /pmc/articles/PMC4457173/ /pubmed/26114015 Text en Copyright © 2014, Harborside Press http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited and is for non-commercial purposes.
spellingShingle Review Article
Peterson, Derek
Schwartz, Joanna
Ibrutinib in Relapsed or Refractory Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia
title Ibrutinib in Relapsed or Refractory Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia
title_full Ibrutinib in Relapsed or Refractory Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia
title_fullStr Ibrutinib in Relapsed or Refractory Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia
title_full_unstemmed Ibrutinib in Relapsed or Refractory Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia
title_short Ibrutinib in Relapsed or Refractory Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia
title_sort ibrutinib in relapsed or refractory mantle cell lymphoma and chronic lymphocytic leukemia
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457173/
https://www.ncbi.nlm.nih.gov/pubmed/26114015
work_keys_str_mv AT petersonderek ibrutinibinrelapsedorrefractorymantlecelllymphomaandchroniclymphocyticleukemia
AT schwartzjoanna ibrutinibinrelapsedorrefractorymantlecelllymphomaandchroniclymphocyticleukemia